The role of pneumolysin in ocular infections with Streptococcus pneumoniae

Current Eye Research
M K JohnsonS Chen

Abstract

Pneumolysin, a cytolytic protein produced by Streptococcus pneumoniae, has many properties which suggest it may be an important virulence factor in pneumococcal ocular infections. To directly test this possibility, we have constructed pneumolysin-negative strains of S. pneumoniae and compared their virulence with that of the wild type in a rabbit model of intracorneal infection. A pneumolysin-negative strain produced by chemical mutagenesis (probably a point mutant) was found to be no less virulent than the parent strain. However, a strain bearing a deletion in the pneumolysin gene showed greatly reduced virulence. This strain produced less pathology while showing significantly higher bacterial counts. These results suggest that a property of the pneumolysin molecule other than its cytolytic (hemolytic) activity may be involved in its pathogenic mechanism of action. This property may be the ability to activate complement, known to be a function of pneumolysin, which results in influx of PMNs, reducing the bacterial counts but also producing tissue damage.

References

Sep 1, 1975·American Journal of Ophthalmology·M K Johnson, J H Allen
Sep 1, 1988·Current Eye Research·M K JohnsonM B Berman
Dec 1, 1986·Journal of Bacteriology·J YotherD E Briles
Oct 1, 1971·Infection and Immunity·C N Shumway, S J Klebanoff
Nov 1, 1972·Infection and Immunity·M K Johnson
Mar 1, 1984·Infection and Immunity·J C PatonA Ferrante
Jan 1, 1982·Current Eye Research·J C HarrisonM K Johnson
Oct 1, 1981·Infection and Immunity·M K JohnsonW A Pierce

❮ Previous
Next ❯

Citations

Mar 26, 2010·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Melissa E SandersMary E Marquart
Jan 29, 2011·Journal of Biomedicine & Biotechnology·Mary E Marquart
Dec 13, 2018·Interdisciplinary Perspectives on Infectious Diseases·Angela H Benton, Mary E Marquart
May 17, 2019·MSphere·Phillip S CoburnMichelle C Callegan
Jun 1, 1995·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D A WatsonJ Verhoef
May 1, 1993·Current Eye Research·J A HobdenR J O'Callaghan
Mar 1, 1992·Current Eye Research·J A HobdenJ J Reidy
Apr 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·T J Mitchell, P W Andrew
Mar 24, 2004·Nature Reviews. Microbiology·Timothy J Mitchell
Nov 5, 2011·Current Eye Research·Anastasia C WeeksRichard O'Callaghan
Dec 14, 2015·Proteomes·Rachida BouhenniJames Bates
Feb 1, 2013·Journal of Ophthalmology·Mary E Marquart, Richard J O'Callaghan
Sep 9, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Kazuki TajimaHiroshi Goto
Dec 3, 2010·Current Eye Research·Melissa E SandersMary E Marquart
Nov 8, 2017·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Joshua Seth EatonChristopher J Murphy
Nov 11, 2019·Microorganisms·Erin T LivingstonMichelle C Callegan
Jun 1, 1994·Infection and Immunity·M C CalleganR J O'Callaghan
Apr 1, 1993·Infection and Immunity·J B RubinsD E Niewoehner
Jul 2, 2003·American Journal of Ophthalmology·Tulaya TungsiripatPeter J McDonnell
Jun 8, 2021·Experimental Eye Research·Lawson Ung, James Chodosh
Oct 25, 2007·BMC Microbiology·Katie L Propst-GrahamMartha J Gentry-Nielsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.